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ABSTRACT
Carcinoma erysipeloides (CE) is an uncommon cutaneous metastasis of advanced breast carcinoma, show-
ing distinctive features and presenting as a well-demarcated erythematous macule or plaque varying in 
size. It also may show a raised border and oedema. The differential diagnoses include erysipelas or celluli-
tis of the breast, or rarely—radiodermatitis. Most of the time CE is associated with advanced breast cancer 
and rarely with neoplastic tumours of the colon, pancreas, oesophagus, uterus, etc. We report a 58-year-old 
woman who presented at the Medical Institute of the Ministry of Internal Affairs with a 1-month history of 
not well-demarcated, erythematous, oedematous patches and plaques on the left and right breast, abdomen 
and both shins, associated with advanced invasive lobular carcinoma of the breast.
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Carcinoma erysipeloides (CE) is an uncommon 
cutaneous metastasis of advanced breast carcinoma. 
Most of the time it is associated with advanced breast 
cancer and rarely with neoplastic tumours of the co-
lon, pancreas, oesophagus, uterus, etc (1).
Carcinoma erysipeloides usually presents with 
well-circumscribed, red to red-violasceous, oede-
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matous skin resembling cellulitis. Usually the skin 
is tender, but also can be asymptomatic. Carcinoma 
erysipeloides is most commonly found on the pre-
sternal area of the body (2,3). It may appear sudden-
ly in normal skin and also within a scar from a pre-
vious surgery. In case of advanced breast cancer, it 
can be found on the other breast. Due to blocking 
of the draining lymphatics and the release of cyto-
kines in the process, the patch or plaque can show a 
raised and oedematous border. Very recent review of 
the literature shows that cutaneous metastases of all 
kinds of tumours range between 0.7–10.0% (3,4). Cu-
taneous metastases are frequently found in women 
with breast cancer, rather than any other neoplasms. 
Rarely, CE can be the first sign of advancing breast 
cancer (3,5). 
Breast cancer is the second most common can-
cer among women, after basal cell carcinoma (6,7). 
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GGT—135.0 IU/L; alkaline phosphatase—204.0 
IU/L; amylase—94.0 IU/L.  
A magnetic resonance tomography (MRT) of 
the head, neck, chest and abdomen regions was per-
formed. It showed enlarged left submandibular, sub-
mental and axillary lymphadenomegaly, bilater-
al pleural effusion, pericardial effusion, and ascites. 
Finding in the uterus was indicative of carcinoma. 
There were generalized osteosclerotic findings. 
A mammologic examination was perfomed. A 
formation in the upper left region of the right breast, 
1 cm in diameter, suspected for breast carcinoma was 
found. A punch biopsy of the breast was initiated and 
histopathologic evaluation confirmed the diagnosis 
of invasive lobular breast carcinoma with perivasal 
infiltration (ER (3+), PR (3+), HER2(-)).
Two pleural punctures were performed in order 
to evacuate 1400 mL of pleural punctate that showed 
groups of large tumour cells.
An abdominal puncture was performed and 
1500 mL of ascitic fluid was evacuated and no tu-
mour cells were found.
The patient was referred to an oncology com-
mittee, so the newly diagnosed breast cancer can be 
evaluated and exact therapy can be initiated.
After TNM staging, a polychemotherapy, target 
therapy with Letrozole Nucleus 2.5 mg, and substitu-
tional therapy were initiated.
Due to deterioration of the general condition 
of the patient, she was admitted to the hospital two 
times (at the Department of Internal Medicine, Pul-
monology, Phtysiatry and Allergology). During her 
As mentioned above, CE is an uncommon type of cu-
taneous metastasis (4,6). Inflammatory breast carci-
noma was first described by C. Rasch in 1931 as car-
cinoma erysipeloides due to its similarity with ery-
sipelas (4,8). It constitutes a total of 1% of breast can-
cer metastases (2,9). The differential diagnosis con-
sists of erysipelas, cellulitis, candidiasis, radioderma-
titis-like changes, etc. (2,3,4). Clinically, carcinoma 
erysipeloides manifests with a well-demarcated, ery-
thematous, tender area with raised, oedematous bor-
ders.  In general, classic clinical features, lack of re-
sponse to topical and systemic therapy should alert 
the physician to the possibility of cutaneous metas-
tases (15). Tumour cells are within the dermal lym-
phatic vessels, with malignant thrombi-induced lym-
phatic obstructions causing the typical induration. 
The pathology of inflammatory carcinoma is spe-
cific, with the deposition of tightly packed neoplas-
tic cells within the superficial and deep lymphatics 
without the pathologic evidence of acute inflamma-
tion. Dermal lymphatic invasion is considered to be 
the main hallmark of CE (11). Gross cystic disease 
fluid protein-15 (GCDFP-15) and estrogen receptor 
protein (ERP) are very specific and valuable mark-
ers for cutaneous metastatic invasive breast carcino-
ma, which can be used in combination for better and 
more accurate diagnosis (12). As mentioned above, 
CE is an uncommon type of cutaneous metastatis. It 
is very rare compared to the more common papules, 
nodules, teleangiectatic, alopetic and zosteriform le-
sions (14). 
CASE REPORT
A 58-year-old woman was presented to the De-
partment of Internal Medicine, Pulmonology, Phtys-
iatry and Allergology with advancing bronchiectat-
ic disease, decompensated chronic respiratory dis-
ease, pulmonary fibrosis, bilateral pleural effusions 
and oedema of the left hip, followed by the left shin, 
right axillary and left submandibular lymphadeno-
megaly. The laboratory evaluation showed:  leuco-
cytes—7.5 x 109/L; erythrocytes—4.79 x 1012/L; hae-
moglobin—136.0 g/L; haematocrit—0.434 L/L; gran-
ulocytes—68.0%; glucose—6.5 mmol/L; creati-
nine—100.0 mmol/L; urea—5.6 mmol/L; AST—88.0 
IU/L; ALT—43.0 IU/L; LDH—264.0 IU/L; creatine 
phosphokinase—114.0 U/L; CK-MB fraction—29.0 
IU/L; total protein—70.0 g/L; albumin—31.0 g/L; Fig. 1. Clinical presentation of the chest region
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second hospitalization two more pleural punctures 
were performed in order to evacuate 1100 mL of 
transudate. 
During her last hospitalization in September 
18 2020, a referral from a dermatologist was made. 
The patient complained of macules that appeared in 
the previous 2 weeks. The dermatological evaluation 
showed not-well-demarcated, erythematous, oede-
matous, tender patches with infiltration, very suspi-
cious for carcinoma erysipeloides (Fig. 1, 2). 
A 4-mm punch biopsy was performed. The 
histopathology of the skin showed massive infiltra-
tion of carcinomatous lymphangitis, probably from 
a breast carcinoma. 
The histological evaluation of the biopsy speci-
men showed dysplastic cells predominantly growing 
within the superficial and deep dermal lymphatic 
vessels, with morphological features resembling in-
flammatory invasive breast carcinoma (Fig. 3, 4).
The laboratory tests showed: leucocytes—14.66 
x 109/L, erythrocytes—3.17 x 1012/L, haemoglo-
bin—112.0 g/L, haematocrit—0.313 L/L, granu-
locytes—68.3%, glucose—4.92 mmol/L, creat-
inin—92.1 mmol/L, urea—8.5 mmol/L, AST—167.0 
IU/L, ALT—265 IU/L, LDH—264.0 IU/L, creatine 
phosphokinase—114.0 U/L, CK-MB fraction—29.0 
IU/L, total protein—54.0 g/L; albumin—20.0 g/L, 
GGT—648.0 IU/L, alkaline phosphatase—667.0 
IU/L, amylase—242.0 IU/L.  
A MRT of the head, neck, chest and abdomen 
revealed three not-well-defined formations in the 
temporo-occipital region and medulla oblongata, 
suspected for metastases. Bilateral pleural effusion, 
right axillary lymphadenomegaly, tumour forma-
tion in left upper quadrant of the right breast, ascites 
and multifocal secondary osteoslerotic lesions were 
established.
Fig. 2. Clinical presentation of the lower abdomen and hip 
region
Fig. 3. Histological findings (x 100) Fig. 4. Histological findings (x 200)
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In seven days, the patient’s general condition 
deteriorated with psychomotoric agitation and mul-
tiorgan insuffiency leading to her death. 
DISCUSSION
We presented a clinical case of a 58-year-old 
woman with 1-month history for a rapidly evolv-
ing erythematous, oedematous and tender lesion on 
her left breast, abdomen and hips that appeared to be 
carcinoma erysipeloides. Our clinical case proves the 
need to maintain great suspicion for dermatitis- or 
erysipelas-like lesions over the breast, which are re-
sistant to classical treatment. Awareness of the dis-
tinctive inflammatory manifestations of CE is essen-
tial for the physicians to establish an early diagnosis 
and accurate treatment in order to increase the over-
all survival rate.
CONLCUSION
Breast cancer is the second most common can-
cer among women. Rarely, this type of cancer can 
metastasize with atypical erythemous—oedematous 
plaques similar to infectious diseases of the skin (ery-
sipelas or cellulitis). The right diagnosis is of a great 
importance for the treatment and survival of the pa-
tient. Our clinical case presents a female patient with 
erysipelas-like lesions on the skin, later diagnosed as 
advanced breast cancer. Through this clinical case 
we would like to underline the importance of rare 
differential diagnoses in clinical cases where the bio-
logical behaviour of the disease cannot be explained. 
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